Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Sagent Pharmaceuticals recalls MethylPREDNISolone Acetate Injectable Suspension

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Presence of Particulate Matter: Potential for black particulates in the drug product.
Products
  • MethylPREDNISolone Acetate Injectable Suspension
Where it was sold

Nationwide in the USA

Nationwide

Units affected
14,360 vials
About this recall
MethylPREDNISolone Acetate Injectable Suspension, USP, 400 mg per 10 mL (40 mg per mL), 1 x 10 mL Multi-Dose Vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195, Made in India. NDC: 25021-820-10